VCIM
IMMX icon

Velan Capital Investment Management’s Immix Biopharma IMMX Stock Holding History

Velan Capital Investment Management’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.74M Buy
740,000
+705,000
+2,014% +$5.18M 4.22% 9
2025
Q4 		$183K Hold
35,000
– – 0.11% 37
2025
Q3 		$73.2K Buy
35,000
+10,000
+40% +$24K 0.07% 47
2025
Q2 		$51.8K Buy
+25,000
New +$50.3K 0.05% 44

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

Velan Capital Investment Management's IMMX Position: Q1 2026 in Review

Velan Capital Investment Management increased its Immix Biopharma (IMMX) stake by 2,014% in Q1 2026, buying an estimated $5.18M and bringing the position to 740,000 shares worth $6.74M. The position accounts for 4.22% of the portfolio, ranked #9.

Velan Capital Investment Management first reported a position in IMMX in Q2 2025 and has held it in 4 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Velan Capital Investment Management held 740,000 shares of Immix Biopharma worth $6.74M as of Q1 2026.
  • Velan Capital Investment Management bought 705,000 Immix Biopharma shares in Q1 2026, an estimated $5.18M.
  • Immix Biopharma made up 4.22% of Velan Capital Investment Management's portfolio in Q1 2026, its #9 holding.
  • Velan Capital Investment Management first reported a position in Immix Biopharma in Q2 2025 and has held it in 4 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Velan Capital Investment Management's 13F filing for Q1 2026, filed 15 May 2026.